Functional experiments confirmed that TRIP13 contributes to ccRCC malignancy by enhancing tumor proliferation (via Ki67 and PCNA), promoting migration and invasion, and facilitating immune escape. Here, MKI67 is linked to nonpapillary renal cell carcinoma.